新天药业(002873.SZ)：欣力康胶囊获准开展用于癌因性疲乏治疗临床试验

Core Viewpoint - The company Xin Tian Pharmaceutical has received approval from the National Medical Products Administration for clinical trials of its Xin Likang capsules, aimed at treating cancer-related fatigue [1] Group 1 - The company has announced the receipt of a clinical trial approval notice for Xin Likang capsules [1] - The clinical trial is specifically for the treatment of cancer-related fatigue [1]